Annotated lowest relative variance abstracts

21918976

Elevated progesterone receptor membrane component 1/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients.
Shakeel U R Mir, Ikhlas S A Ahmed, Susanne Arnold, Rolf J Craven
(Department of Molecular and Biomedical Pharmacology, Markey Cancer Center, University of Kentucky, Lexington, KY, USA.)
Int. J. Cancer

death biomarkers protein tumor motility tumor vivo growth breast cervical cell_lines receptor type receptors cancers activity levels tumor samples squamous_cell cancers sclc adenocarcinomas tissue levels sclc samples tumors sclc cell_lines sclc cell survival adenocarcinomas tumors had levels survival cells cells plasma patients patients tumor serum

25407113

Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
Emmanuel Buc, David Orry, Olivier Antomarchi, Johan Gagnière, David Da Ines, Denis Pezet
(Department of Digestive and HPB Surgery, CHU Estaing - 1, Place Lucie et Raymond Aubrac, 63003 Clermont-Ferrand, France. ebuc@chu-clermontferrand.fr.)
World J Surg Oncol

patients metastatic adenocarcinoma chemotherapy surgery patients metastatic metastasis liver cases metastasis tumor perioperative patients had chemotherapy regimen surgery median chemotherapy surgery months resection cases patients had postoperative_complications median days patients had postoperative chemotherapy recurrence months after surgery after months patients recurrence months after treatment distant_metastases after neoadjuvant_chemotherapy

14568680

Histology-related variation in the treatment and survival of patients with lung carcinoma in Canada.
Lin Xie, Anne-Marie Ugnat, Judy Morriss, Robert Semenciw, Yang Mao
(Surveillance and Risk Assessment Division, Center for Chronic Disease Prevention and Control, Population and Public Health Branch, Health Canada, 120 Colonnade Road, Address Locator 6702A, Ottawa, Ont ...)
Lung Cancer

treatment survival survival trends patients invasive regional stage survival model survival rate patients had survival patients stage ii nsclc surgery alone patients stage_iii nsclc had 5-year_survival rate after chemotherapy plus radiotherapy patients chemotherapy had survival years patients cases cell sclc survival patients chemotherapy plus radiotherapy chemotherapy survival surgical patients stage nsclc patients survival patients screening diagnosis treatment

19879423

Clusterin (CLU) and lung cancer.
F Panico, F Rizzi, L M Fabbri, Saverio Bettuzzi, F Luppi
(Department of Oncology, Hematology and Respiratory Diseases, Section of Respiratory Diseases, University of Modena and Reggio Emilia, 41100 Modena, Italy.)
Adv. Cancer Res.

groups behaviors cancers nsclc sclc nsclc patients survival rate tumor recurrence therapy treatment treatment response radiotherapy cell_lines after exposure radiotherapy protein sirna mrna cell_lines cells chemotherapy radiotherapy metastatic_potential vivo nsclc patients had tumors cancers positive patients radiotherapy induction resistance cancers patients local treatment

25076720

Clinical-epidemiological study on advanced non-small cell lung cancer.
L Miron, M Bosanceanu, Raluca Filimon, F D Petrariu
()
Rev Med Chir Soc Med Nat Iasi

nsclc patients nsclc regional interval index nsclc patients years index age diagnosis age groups cases adenocarcinomas patients stage_iiia nsclc stage patients primary chemotherapy complications hemoptysis cachexia atelectasis surgery stage_iiia nsclc patients nsclc age groups years adenocarcinoma patients primary chemotherapy patients stage_iiia complications

15500010

Genomic-wide cDNA microarray screening to correlate gene expression profile with chemoresistance in patients with advanced lung cancer.
Fumihiro Oshita, Mizuki Ikehara, Akiko Sekiyama, Nobuyuki Hamanaka, Haruhiro Saito, Kouzo Yamada, Kazumasa Noda, Yoichi Kameda, Yohei Miyagi
(Department of Thoracic Oncology, Laboratory for Molecular Diagnostics and Pathology, Kanagawa Cancer Center, Nakao 1-1-2, Asahi-ku, Yokohama 241-0815, Japan. foshita@kcch.jp)
J. Exp. Ther. Oncol.

expression levels genes tumors tumor response chemotherapy patients patients had sclc had nsclc patients platinum-based_chemotherapy patients sclc patients nsclc chemotherapy tumors chemotherapy expression levels genes tumor specimens human gene expression levels tumor response chemotherapy expression genes non-responders responders chemotherapy inflammatory antigen mhc_class ii gene expression levels patients sclc nsclc expression levels resistant genes mean expression genes sclc patients nsclc patients genes tumor tissue patients expression levels genes chemosensitivity

17695477

Expression of mRNA MMP-7 and mRNA TIMP-1 in non-small cell lung cancer.
J Safranek, L Holubec, O Topolcan, M Pesta, J Klecka, J Vodicka, J Finek, S Kormunda, M Pesek
(Department of Surgery, Faculty Hospital, and Medical Faculty, Charles University in Pilsen, Czech Republic.)
Anticancer Res.

metastasis invasion tumour cells patients carcinoma nsclc tissue group patients mmp cases degrees rna method expression level expression ratio gene expression mrna nsclc tissue tissue expression mrna tissue expression mrna adenocarcinoma nsclc had group patients range ratio normal nsclc

11404151

Survival, disease-free interval, and associated tumor features in patients with colon/rectal carcinomas and their resected intra-pulmonary metastases.
S Zink, G Kayser, H J Gabius, K Kayser
(Department of Pathology, Thoraxklinik, Heidelberg, Germany.)
Eur J Cardiothorac Surg

group patients prognostic_factors patients primary metastases patients pulmonary_metastases primary stage grading localization surgical primary levels localization metastases vs lymph_nodes therapy metastases survival after diagnosis primary carcinomas after resection pulmonary_metastases survival median interval diagnosis primary thoracotomy disease months patients tumor primary pn0 median diameter metastasis mm median cm patients mediastinal lymph_nodes resection metastases patients metastases survival metastases serum_cea level treatment stage grade primary liver_metastases treatment metastases postoperative residual stage had survival pulmonary_metastases patients primary survival patients metastases survival after thoracotomy metastases intrapulmonary thoracotomy

11013372

Protracted survival after resection of metastatic uveal melanoma.
T Aoyama, M J Mastrangelo, D Berd, F E Nathan, C L Shields, J A Shields, E L Rosato, F E Rosato, T Sato
(Department of Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.)
Cancer

resection metastatic patients patients patients metastasis primary metastasis patients liver_metastases metastases brain_metastasis patients metastases liver median metastasis years patients metastasis patients resection metastasis surgical complications median recurrence after months months recurrence patients patients had recurrence patients metastasis years recurrence years after surgery patients metastases years patients recurrence metastasis years after surgery metastatic survival patients trial patients resection treatment surgery

22381451

Outcomes after surgical management of synchronous bilateral primary lung cancers.
Asad A Shah, Michael E Barfield, Chris R Kelsey, Mark W Onaitis, Betty Tong, David Harpole, Thomas A D'Amico, Mark F Berry
(Division of Cardiovascular and Thoracic Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.)
Ann. Thorac. Surg.

synchronous primary cancers metastatic disease patients masses patients n2_disease invasive mediastinal_staging distant_metastases patients primary guidelines survival death recurrence postoperative_complications primary cancers patients patients had unilateral thoracoscopic had thoracoscopic median days patients had grade perioperative death patients therapy patients treatment survival patients tumors had patients treatment primary patients